Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale-Reference-Cited by-同舟云学术

Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale

Published:2024-04-17 Issue: Volume: Page:1-13
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Miyake Makito¹^ORCID,Nishimura Nobutaka¹,Oda Yuki¹,Miyamoto Tatsuki¹,Tomizawa Mitsuru¹,Shimizu Takuto¹,Hori Shunta¹,Morizawa Yosuke¹,Gotoh Daisuke¹,Nakai Yasushi¹,Torimoto Kazumasa¹,Fujii Tomomi²³,Tanaka Nobumichi¹⁴,Fujimoto Kiyohide¹

Affiliation:

1. Department of Urology, Nara Medical University, Kashihara, Nara, Japan

2. Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara, Japan

3. Division of Fostering Required Medical Human Resources, Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan

4. Department of Prostate Brachytherapy, Nara Medical University, Kashihara, Nara, Japan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2340885

Reference41 articles.

1. Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma

2. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.

3. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

4. Aspects of taste and compliance in patients with cancer

5. Self-reported taste and smell changes during cancer chemotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial;Methods and Protocols;2024-07-29

2. Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan;Cancers;2024-07-25